- Home
- CHWY vs SNN Comparison
CHWY vs SNN Comparison
Compare CHWY & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHWY
- SNN
- Stock Information
- Founded
- CHWY 2010
- SNN 1856
- Country
- CHWY United States
- SNN United Kingdom
- Employees
- CHWY N/A
- SNN N/A
- Industry
- CHWY Catalog/Specialty Distribution
- SNN Industrial Specialties
- Sector
- CHWY Consumer Discretionary
- SNN Health Care
- Exchange
- CHWY Nasdaq
- SNN Nasdaq
- Market Cap
- CHWY 16.5B
- SNN 15.2B
- IPO Year
- CHWY 2019
- SNN 1999
- Fundamental
- Price
- CHWY $33.07
- SNN $36.76
- Analyst Decision
- CHWY Strong Buy
- SNN Hold
- Analyst Count
- CHWY 25
- SNN 4
- Target Price
- CHWY $45.17
- SNN $33.50
- AVG Volume (30 Days)
- CHWY 7.0M
- SNN 631.7K
- Earning Date
- CHWY 12-03-2025
- SNN 10-30-2025
- Dividend Yield
- CHWY N/A
- SNN 1.99%
- EPS Growth
- CHWY N/A
- SNN 59.91
- EPS
- CHWY 0.35
- SNN 0.56
- Revenue
- CHWY $12,345,235,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- CHWY $8.72
- SNN $7.85
- Revenue Next Year
- CHWY $7.87
- SNN $5.43
- P/E Ratio
- CHWY $94.68
- SNN $65.86
- Revenue Growth
- CHWY 9.17
- SNN 5.35
- 52 Week Low
- CHWY $28.82
- SNN $23.69
- 52 Week High
- CHWY $48.62
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- CHWY 33.79
- SNN 54.85
- Support Level
- CHWY $31.76
- SNN $35.74
- Resistance Level
- CHWY $33.88
- SNN $37.06
- Average True Range (ATR)
- CHWY 1.14
- SNN 0.47
- MACD
- CHWY -0.27
- SNN 0.08
- Stochastic Oscillator
- CHWY 20.25
- SNN 57.75
About CHWY Chewy Inc.
Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.